Promotive Effect and Its Molecular Mechanism of KLF5 on Gemcitabine-induced Apoptosis in Human LungAdenocarcinoma Cell Line H441

DONG You-zhi, LIAO Yong

Abstract

To investigate the effects of krüppel-like factor 5 (KLF5) overexpression on gemcitabine (GEME)-induced lung adenocarcinoma cell apoptosis and its molecular mechanisms. Methods Lung adenocarcinoma cell line H441 were transfected with KLF5 plasmid or control plasmid. 68 h later, cells were treated with 100 nmol/L GEME for 4 h,then cell number counting and flow cytometry were applied to detect cell proliferation and apoptosis; Western blot were used to analyse the expression level of KLF5, RT-PCR were used to analyse the KLF5gene, apoptosis-related genes CD95 and BAX; Immunofluorescence staining was performed to detect the expression level of apoptosis-related protein Caspase 3. Results The overexpressions of KLF5 protein were detected in cultured- lung adenocarcinoma cell line H441 cells when KLF5 plasmids were transfected 68 h. Further flow cytometry, overexpression of KLF5 in H441 cell line affected the biological process of apoptosis significantly. No significant changes of apoptosis and expression level of CD95 and BAXin H441 cells were observed by KLF5 overexpression without GEME treatment (P >0.05). Under GEME induction, the proportion of apoptotic cells and expression level of CD95 and BAXwere increased significantly in H441 cells by KLF5 overexpression, compared with that of control (P <0.05); The overexpression of KLF5 restrained the proliferation of H441 cells; Immunofluorescence staining of Caspase 3 was also enhanced after KLF5 overexpression. Conclusion Under GEME induction, the overexpression of KLF5 promoted the apoptosis of lung adenocarcinoma cell line H441 in vitro, possibly through the inhibition of cell proliferation and repair/activation of apoptosis pathway proteins, such as Caspase 3, CD95 and BAX.

Keywords: Krüppel-like factor 5, Gemcitabine, Apoptosis, Lung adenocarcinoma 


Full Text:

PDF


References


Jemal A. Bray F. Center MM, et al. Global cancer statistics. С A Cancer J Clin. 2011 ;61( 2): 69-90.

Patrikidou Al. Sinapi 1. Kegnault H. et al. Gemcitabine and oxaliplatin chemotherapy for advanced hepatocellular carcinoma after failure of anti-angiogenic therapies. Invest New Drugs* 2014;32(5): 1028-1035.

Meyer SK. Hasenstein JR. Baktula A. et al. KrUppel-like factor 5 is not required for K-RasG12 d lung tumorigenesis, but represses ABCG2 expression and is associated with better disease-specific survival. Am J Pathol. 2010; 177 (3): 1503- 1513.

Bieker JJ. KrUppel-like factors: three fingers in many pies. J Biol Chem.2001;276(37);34355-34358.

Chen C. Bhalala HV. Qiao H. et al. A possible tumor suppressor role of the KLF5 transcription factor in human breast cancer. Oncogene.2002;21 (43):6567-6572.

Samakoglu S. Deevi DS. Li H. et al. Preclinical rationale for combining an KGFR antibody with cisplatin/gemcitabine for the treatment of NSCLC. Cancer Genomics Proteomics. 2012; 9 (2): 77-92.

Wang F. Liu X. Yang P. et al. Loss of TACSTD2 contributed to squamous cell carcinoma progression through attenuating TAp63-dependent apoptosis. Cell Death is.2014;5:el 133.

Schickel R, Park SM. Murmann AК. et al. miR-200c regulates induction of apoptosis through CD95 by targeting FAP-1. Mol Cell.2010;38(6):908-915.

Tanaka R. Ishiyama T. Uchihara Г. Et al. Expression of the Bax inhibitor-1 gene in pulmonary adenocarcinoma. Cancer. 2006;106(3): 648-653.

Ho YT. Lu CC. Yang JS. et al. Berberine induced apoptosis via promoting the expression of caspase-8. -9 and -3. apoptosis-inducing factor and endonuclease G in SCC-4 human tongue squamous carcinoma cancer cells. Anticancer Res. 2009;29(10):4063-4070.

Fiandalo MV, Kyprianou N. Caspase control: protagonists of cancer cell apoptosis. Exp Oncol,2012;34(3): 165-175.

Hughes MA. Harper N. Butterworth M. et al. Reconstitution of the death-inducing signaling complex reveals a substrate switch that determines CD95-mediated death or survival. Mol Cell,2009;35(3>:265-279.

Moscetti L. Nelli F. Padalino D, et al. Gemcitabine and cisplatin in the treatment of elderly patients with advanced non¬small cell lung cancer: impact of comorbidities on safety and efficacy outcome. J Chemother,2005; 17(6):685-692.

Yang Y, Goldstein BG, Chao HH, et al. KLF4 and KLF5 regulate proliferation, apoptosis and invasion in esophageal cancer cells. Cancer Biol Ther,2005;4(ll):1216-1221.

Nandan MO, Yoon HS, Zhao W, et al. KrUppel-like factor 5 mediates the transforming activity of oncogenic H-Ras. ()ncogene,2004;23( 19):3404-3413.

Nandan MO, Chanchevalap S, Dalton WB. etui. KrUppel-like factor 5 promotes mitosis by activating the cyclin Bl/Cdc2 complex during oncogenic Ras-mediated transformation. FKBS Lett, 2005; 579(21) *4757-4762.

Brentnall M. Rodriguez-Menocal L. De Guevara RI, et al. Caspase-9, caspase-3 and caspase-7 have distinct roles during intrinsic apoptosis. BMC Cell Biol,2013; 14:32. doi: 10.1186/ 1471-2121-14-32.


Refbacks

  • There are currently no refbacks.